Skip to main content
. 2016 May 17;3(7):482–494. doi: 10.1002/acn3.317

Table 8.

Classes of dopaminergic therapy in treated PD subjects

Variable Treated PD subjects (N = 284)
Class of dopaminergic therapya
Dopamine replacements 85 (31.60%)
Dopamine agonists 65 (24.16%)
COMT inhibitors 0 (0.00%)
Mao‐B inhibitors 106 (39.41%)
Anti‐cholinergics 2 (0.74%)
Other (amantadine, apomorphine SQ) 21 (7.81%)
Missing 15
a

Note: Subjects may have more than one class of DT listed.

Report generated on data submitted as of: 15 September 2014.